Literature DB >> 9878452

Intracellular survival of Haemophilus somnus in bovine blood monocytes and alveolar macrophages.

S M Gomis1, D L Godson, G A Wobeser, A A Potter.   

Abstract

The mechanisms used by Haemophilus somnus to survive and multiply within bovine mononuclear phagocytes are not fully understood. In order to study the interaction between bovine mononuclear phagocytes and H. somnus, a colorimetric assay using 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenylItetrazolium bromide (MTT) was developed to assess the survival of H. somnus within cultured bovine blood monocytes (BBM). Using this system, it was found that H. somnus was able to survive within BMM in vitro, and the kinetics of its survival were similar to that seen in BBM isolated from experimentally infected cattle. Using ultrastructural studies, it was possible to demonstrate the survival of H. somnus in freshly isolated bovine mononuclear phagocytes in membrane-bound vacuoles. To determine if activation of macrophage function would result in elimination of intracellular H. somnus, BBM were treated with E. coli lipopolysaccharide (LPS) or recombinant bovine (rBo) cytokines, interferon-gamma (IFN-gamma), granulocyte macrophage colony stimulating factor (GM-CSF), tumour necrosis factor-alpha (TNF-alpha) or interleukin-1beta (IL-1beta). Treatment of BBM with rBoIFN-gamma, rBoGM-CSF or E. coli LPS resulted in decreased intracellular survival of H. somnus at 18 and 48 h, whereas BBM treated with rBoTNF-alpha or rBoIL-1beta had reduced intracellular survival of H. somnus only at 18 h. However, none of these treatments resulted in complete elimination of the intracellular bacteria. The ability of H. somnus to survive and multiply in both freshly isolated and cytokine-treated cultured BBM demonstrated the capability of H. somnus to escape from macrophage killing mechanisms. This capability may play a role in the dissemination of H. somnus infection in the body. Copyright 1998 Academic Press

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878452     DOI: 10.1006/mpat.1998.0228

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

1.  The Role of luxS in Histophilus somni Virulence and Biofilm Formation.

Authors:  Yu Pan; Shivakumara Siddaramappa; Indra Sandal; Allan Dickerman; Aloka B Bandara; Thomas J Inzana
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

2.  Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines.

Authors:  Charles S Berenson; Timothy F Murphy; Catherine T Wrona; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Haemophilus somnus induces apoptosis in bovine endothelial cells in vitro.

Authors:  M J Sylte; L B Corbeil; T J Inzana; C J Czuprynski
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Effector prediction in host-pathogen interaction based on a Markov model of a ubiquitous EPIYA motif.

Authors:  Shunfu Xu; Chao Zhang; Yi Miao; Jianjiong Gao; Dong Xu
Journal:  BMC Genomics       Date:  2010-12-01       Impact factor: 3.969

5.  Incorporation of N-acetylneuraminic acid into Haemophilus somnus lipooligosaccharide (LOS): enhancement of resistance to serum and reduction of LOS antibody binding.

Authors:  Thomas J Inzana; Gretchen Glindemann; Andrew D Cox; Warren Wakarchuk; Michael D Howard
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

6.  Histophilus somni Survives in Bovine Macrophages by Interfering with Phagosome-Lysosome Fusion but Requires IbpA for Optimal Serum Resistance.

Authors:  Yu Pan; Yuichi Tagawa; Anna Champion; Indra Sandal; Thomas J Inzana
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

7.  Identification, structure, and characterization of an exopolysaccharide produced by Histophilus somni during biofilm formation.

Authors:  Indra Sandal; Thomas J Inzana; Antonio Molinaro; Christina De Castro; Jian Q Shao; Michael A Apicella; Andrew D Cox; Frank St Michael; Gretchen Berg
Journal:  BMC Microbiol       Date:  2011-08-19       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.